Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy kids and adults will need to go through placebo-controlled clinical trials before they can get approved.

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups.